Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:business_executive
|
| gptkbp:appointed_as_CEO_of_Gilead_Sciences |
2019
|
| gptkbp:boardMemberOf |
gptkb:Gilead_Sciences
gptkb:Pharmaceutical_Research_and_Manufacturers_of_America_(PhRMA) |
| gptkbp:education |
gptkb:Columbia_University
gptkb:Georgetown_University |
| gptkbp:employer |
gptkb:Gilead_Sciences
|
| gptkbp:fieldOfStudy |
biology
business administration |
| gptkbp:formerPosition |
gptkb:Roche
CEO of Roche Pharmaceuticals Chief Operating Officer of Roche Diagnostics |
| https://www.w3.org/2000/01/rdf-schema#label |
Daniel O’Day
|
| gptkbp:knownFor |
leadership in pharmaceutical industry
COVID-19 response at Gilead Sciences |
| gptkbp:nationality |
gptkb:American
Irish |
| gptkbp:occupation |
gptkb:business_executive
CEO |
| gptkbp:position |
Chairman and CEO of Gilead Sciences
|
| gptkbp:predecessor_at_Gilead_Sciences |
gptkb:John_Milligan
|
| gptkbp:bfsParent |
gptkb:Gilead_Sciences
gptkb:Gilead |
| gptkbp:bfsLayer |
5
|